Indaptus Therapeutics Inc.
13F holders, Q1 2024 (March 31)17holders
1famous investor
$2.24avg. 13F price*
At the end of Q1 2024, 17 institutions reported holding Indaptus Therapeutics Inc. in their 13F filings. The largest holders were Vanguard Group Inc. ($574K), Investment House LLC ($229K) and Geode Capital Management, LLC ($123K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Indaptus Therapeutics Inc.
- CUSIP
- 45339J105
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $32K |
| Exits | 3 | $29K |
Ownership 17 holders
| Vanguard Group Inc. | 0.00% | No change | 256,265 | $574K |
| Investment House LLC | 0.01% | No change | 102,437 | $229K |
| Geode Capital Management, LLC | 0.00% | No change | 54,767 | $123K |
| Strategy Asset Managers LLC | 0.02% | No change | 45,336 | $102K |
| Pine Valley Investments Ltd Liability Co | 0.01% | Reduce -0.2% | 44,145 | $99K |
| Renaissance Technologies | 0.00% | Reduce -11.2% | 26,100 | $58K |
| Debussy Capital Management LP | 0.02% | No change | 24,000 | $52K |
| Virtu Financial LLC | 0.00% | New | 14,232 | $32K |
| State Street Corp. | 0.00% | Reduce -32.9% | 13,073 | $29K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -13.4% | 4,066 | $9K |
| UBS Group AG | 0.00% | Reduce -47.7% | 1,936 | $4K |
| Morgan Stanley | 0.00% | No change | 884 | $2K |
| Bangor Savings Bank | 0.00% | No change | 400 | $896 |
| Wells Fargo & Company | 0.00% | Add +1.0% | 105 | $235 |
| JPMorgan Chase & Co. | 0.00% | Add +55.6% | 14 | $31 |
| Group One Trading LLC | 0.00% | No change | 7 | $16 |
| Qube Research & Technologies Ltd | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is INDAPTUS THERAPEUTICS INC's weight in each manager's 13F, not the share of Indaptus Therapeutics Inc. the manager owns.